Russian company launches international clinical trial of diabetes complications drug | News
Polisan has initiated an international clinical trial to evaluate Citoflavin (inosine/nicotinamide/riboflavin/succinic acid) for the treatment of diabetic polyneuropathy, a common complication of diabetes. According to the company’s press service, the…